RxDoctor Payments Data

Abdel Rahman Lataifeh

Critical Care Medicine · Pikeville, KYNPI 1003122441

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Baxter Healthcare at 34.5% of the total. That places this record below the midpoint for critical care medicine clinicians in KY, where the typical reported total is $184.

$121in general payments, 2019–2025

Across 6 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$42
  • Viatris Specialty LLC$28
  • Verona Pharma, Inc.$22
  • GSK$16
  • Amgen$14

What the payments were for

  • Food & beverage$121100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$121 in reported general payments places this provider in the 40th percentile of 60 critical care medicine providers in Kentucky.

See all critical care medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$220,697
Medicare patients
458
Services billed
1,996

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter308$226,102
Breztri AerosphereBudesonide/Glycopyr/Formoterol77$52,105
Pirfenidone16$49,307
Breo ElliptaFluticasone/Vilanterol53$24,333
SymbicortBudesonide/Formoterol Fumarate37$10,125
EliquisApixaban14$7,942
Wixela InhubFluticasone Propion/Salmeterol32$5,182
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,936
Roflumilast28$2,162
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$2,143
Albuterol Sulfate HfaAlbuterol Sulfate67$1,801
Ipratropium Bromide22$723
Ventolin HfaAlbuterol Sulfate12$663
Montelukast Sodium51$290
Methylprednisolone31$251

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$16$255,371372 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 60 critical care medicine providers in Kentucky.

Other critical care medicine in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →